About
Birdwood Therapeutics is a biopharmaceutical company dedicated to discovering and developing innovative therapies across a broad spectrum of diseases. Leveraging proprietary AI-driven platforms and advanced genomics, the company focuses on rare genetic disorders, oncology, and metabolic diseases. Its modular drug discovery pipeline accelerates lead identification and preclinical validation, enabling rapid progression to clinical trials. Birdwood’s collaborative culture and commitment to translational research position it as a forward-thinking partner in the therapeutic landscape.
